Treatment News : Gingko May Lower Efavirenz Blood Levels

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » May 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


May 22, 2009

Gingko May Lower Efavirenz Blood Levels

Combining the herbal therapy gingko biloba with efavirenz (found in Sustiva and Atripla) could result in efavirenz treatment failure, according to a single case report published in the June 1 issue of AIDS and reported by aidsmap.

Experts already recommend that people with HIV tell their providers about all of the medications, vitamins, herbs and supplements they take. This is critical, because when a person starts an HIV regimen it is important to understand the source of any potential side effects and to guard against drug interactions. The drug interaction potential between some herbs and HIV medications, however, is not well understood. This is the case for the herb gingko biloba, which is often used to boost concentration, memory and mood.

In a letter in AIDS, Dirk-Jan Wiegman, MD, from the Onze Lieve Vrouwe Gasthuis in Amsterdam and his colleagues describe the case of an HIV-positive patient who had developed resistance to both efavirenz and emtricitabine (Emtriva) despite excellent treatment adherence. Wiegman’s team asked the man about all other drugs and supplements he’d been taking during his time on efavirenz and found that the only other substance being used was gingko biloba.

Since gingko biloba is metabolized through a similar liver pathway as efavirenz, the P450 enzyme system, and has been found to interact with other drugs, the researchers turned to stored blood samples from the patient to determine how his efavirenz blood levels had been affected over time.

Wiegman and his colleagues found that the man’s efavirenz blood levels had initially been within normal levels when he first began his regimen in 2006, but then dropped significantly after he started taking gingko biloba. While it is not possible to draw firm conclusions from a single case report, the authors suggest: “An intake of [gingko biloba] can decrease [blood levels] of efavirenz, may result in virological failure and should be discouraged.”

Search: Gingko biloba, efavirenz, Sustiva, Atripla, Emtriva, emtricitabine, drug interaction

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.